Preclinical Screening Platform Identifies Azatadine-Dimaleate as a Potent Repurposed Therapeutic Against SARS-CoV-2 Infection. Ali A, Courtney D, Broadbent L, Sharma P, et al. J Med Virol 2025;97:e70713.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ali A, Courtney D, Broadbent L, Sharma P, et al. Preclinical Screening Platform Identifies Azatadine-Dimaleate as a Potent Repurposed Therapeutic Against SARS-CoV-2 Infection. J Med Virol 2025;97:e70713.
PMID: 41263140